• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管之前使用过抗疟药物,但仍感染了三日疟原虫。

Plasmodium malariae infection in spite of previous anti-malarial medication.

作者信息

Müller-Stöver Irmela, Verweij Jaco J, Hoppenheit Barbara, Göbels Klaus, Häussinger Dieter, Richter Joachim

机构信息

Tropenmedizinische Ambulanz, Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Moorenstr. 5, 40225 Düsseldorf, Germany.

出版信息

Parasitol Res. 2008 Feb;102(3):547-50. doi: 10.1007/s00436-007-0804-4. Epub 2007 Dec 2.

DOI:10.1007/s00436-007-0804-4
PMID:18060428
Abstract

Plasmodium malariae is regarded as usually being susceptible to all anti-malarials whether applied for prophylaxis or treatment. We report on three cases of P. malariae infection which occurred 12-14 weeks after anti-malarial chemoprophylaxis or treatment with mefloquine or atovaquone/proguanil. The most likely explanation for the failure of mefloquine and atovaquone/proguanil to prevent quartan malaria occurring some months later is the insufficient effect on the particularly long-lasting pre-erythrocytic development stages of P. malariae.

摘要

间日疟原虫通常被认为对所有用于预防或治疗的抗疟药敏感。我们报告了3例间日疟原虫感染病例,这些病例发生在使用甲氟喹或阿托伐醌/氯胍进行抗疟化学预防或治疗后的12 - 14周。甲氟喹和阿托伐醌/氯胍未能预防数月后发生的三日疟最可能的解释是,它们对间日疟原虫特别持久的红细胞前期发育阶段的作用不足。

相似文献

1
Plasmodium malariae infection in spite of previous anti-malarial medication.尽管之前使用过抗疟药物,但仍感染了三日疟原虫。
Parasitol Res. 2008 Feb;102(3):547-50. doi: 10.1007/s00436-007-0804-4. Epub 2007 Dec 2.
2
Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.阿托伐醌-氯胍化学预防及氯喹治疗对三日疟原虫感染无效。
Travel Med Infect Dis. 2016 Nov-Dec;14(6):644-645. doi: 10.1016/j.tmaid.2016.08.005. Epub 2016 Aug 18.
3
Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.在pmcytb第268位密码子无突变的情况下,间日疟原虫导致症状延迟出现及阿托伐醌-氯胍化学预防突破。
PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004068. doi: 10.1371/journal.pntd.0004068. eCollection 2015.
4
Recrudescing Plasmodium malariae infection despite appropriate treatment in an immigrant toddler.一名移民幼儿在接受适当治疗后,间日疟原虫感染仍复发。
Paediatr Int Child Health. 2018 Nov;38(4):290-293. doi: 10.1080/20469047.2017.1378797. Epub 2017 Oct 4.
5
The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.氯喹加氯胍、甲氟喹以及阿托伐醌加氯胍对丹麦旅行者进行疟疾化学预防的效果
J Travel Med. 2003 May-Jun;10(3):150-4. doi: 10.2310/7060.2003.35746.
6
Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria.
Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):682. doi: 10.1016/s0035-9203(96)90435-6.
7
A case of Plasmodium malariae recurrence: recrudescence or reinfection?疟原虫疟疾复发:再燃还是再感染?
Malar J. 2019 May 14;18(1):169. doi: 10.1186/s12936-019-2806-y.
8
A case of imported Plasmodium malariae malaria.输入的文本为:疟原虫疟疾的输入性病例。
Ann Lab Med. 2012 May;32(3):229-33. doi: 10.3343/alm.2012.32.3.229. Epub 2012 Apr 18.
9
Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.阿托伐醌/氯胍:用于预防恶性疟原虫疟疾的应用综述
Drugs. 2003;63(6):597-623. doi: 10.2165/00003495-200363060-00006.
10
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.恶性疟原虫细胞色素b基因的突变与接受阿托伐醌-氯胍治疗的疟疾患者中寄生虫复发延迟有关。
Malar J. 2008 Nov 20;7:240. doi: 10.1186/1475-2875-7-240.

引用本文的文献

1
A case of Plasmodium malariae recurrence: recrudescence or reinfection?疟原虫疟疾复发:再燃还是再感染?
Malar J. 2019 May 14;18(1):169. doi: 10.1186/s12936-019-2806-y.
2
Multiplex real-time PCR for diagnosing malaria in a non-endemic setting: a prospective comparison to conventional methods.多重实时 PCR 在非流行地区疟疾诊断中的应用:与传统方法的前瞻性比较。
Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2323-2329. doi: 10.1007/s10096-018-3378-4. Epub 2018 Sep 26.
3
Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.

本文引用的文献

1
Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight.微小和亚显微的恶性疟原虫感染,而非感染引起的炎症,与低出生体重有关。
Am J Trop Med Hyg. 2006 Nov;75(5):798-803.
2
Patterns of imported malaria at the academic medical center, Amsterdam, the Netherlands.荷兰阿姆斯特丹学术医学中心的输入性疟疾模式。
J Travel Med. 2006 Jan-Feb;13(1):2-7. doi: 10.1111/j.1708-8305.2006.00003.x.
3
Is quartan malaria safely prevented by mefloquine prophylaxis?
青蒿琥酯/伯氨喹抗药性对疟疾的临床影响:系统评价和荟萃分析。
J Antimicrob Chemother. 2018 Mar 1;73(3):581-595. doi: 10.1093/jac/dkx431.
4
Clinical implications of a gradual dormancy concept in malaria.疟疾中逐渐休眠概念的临床意义
Parasitol Res. 2016 Jun;115(6):2139-48. doi: 10.1007/s00436-016-5043-0. Epub 2016 Apr 15.
5
A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species.一个用于检测疟原虫种类的聚合酶链反应(PCR)方案的临床试验联盟内部的质量控制程序。
J Clin Microbiol. 2014 Jun;52(6):2144-9. doi: 10.1128/JCM.00565-14. Epub 2014 Apr 16.
6
Recrudescence of Plasmodium malariae after Quinine.奎宁治疗后间日疟原虫的复发
Case Rep Med. 2014;2014:590265. doi: 10.1155/2014/590265. Epub 2014 Feb 12.
7
High prevalence and genetic diversity of Plasmodium malariae and no evidence of Plasmodium knowlesi in Bangladesh.高疟原虫和疟原虫的流行率和遗传多样性,以及在孟加拉国没有发现疟原虫诺氏的证据。
Parasitol Res. 2014 Apr;113(4):1537-43. doi: 10.1007/s00436-014-3798-8. Epub 2014 Feb 28.
8
Epidemiology of Plasmodium infections in Flores Island, Indonesia using real-time PCR.印度尼西亚弗洛雷斯岛疟原虫感染的流行病学研究:运用实时荧光定量聚合酶链反应法
Malar J. 2013 May 24;12:169. doi: 10.1186/1475-2875-12-169.
9
Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?为什么疟原虫疟疾感染有时会发生,尽管以前有抗疟药物治疗?
Parasitol Res. 2012 Aug;111(2):943-6. doi: 10.1007/s00436-012-2851-8. Epub 2012 Feb 18.
10
What is the evidence for the existence of Plasmodium ovale hypnozoites?卵形疟原虫休眠子是否存在的证据是什么?
Parasitol Res. 2010 Nov;107(6):1285-90. doi: 10.1007/s00436-010-2071-z. Epub 2010 Oct 5.
J Travel Med. 2004 Mar-Apr;11(2):125-6. doi: 10.2310/7060.2004.16955.
4
Clinical virology in real time.实时临床病毒学
J Clin Virol. 2002 Dec;25 Suppl 3:S3-12. doi: 10.1016/s1386-6532(02)00197-x.
5
Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia.印度尼西亚南苏门答腊的抗氯喹恶性疟原虫。
Lancet. 2002 Jul 6;360(9326):58-60. doi: 10.1016/S0140-6736(02)09336-4.
6
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.阿托伐醌-氯胍与氯喹-氯胍用于非免疫旅行者疟疾预防的随机双盲研究。马拉隆国际研究团队。
Lancet. 2000 Dec 2;356(9245):1888-94. doi: 10.1016/s0140-6736(00)03260-8.
7
Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites.耐药性突变揭示了疟原虫细胞色素b的阿托伐醌结合结构域。
Mol Microbiol. 1999 Aug;33(4):704-11. doi: 10.1046/j.1365-2958.1999.01515.x.
8
Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria.
Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):682. doi: 10.1016/s0035-9203(96)90435-6.
9
Problems in the therapy of mixed malarial infections: a case of infection with Plasmodium falciparum and P. malariae treated with mefloquine and halofantrine.混合性疟疾感染的治疗问题:1例恶性疟原虫和三日疟原虫感染患者使用甲氟喹和卤泛群治疗的病例
Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):688. doi: 10.1016/0035-9203(93)90295-2.